(2020), CRP is a valuable biomarker of inflammation and can be used in the prediction of the severity of acute diverticulitis. Govindarajah et al. (2014) reported that; there was a significant decrease in serum CRP levels in response to co-amoxicillin gentamycin therapy in a case of appendiceal or acute colonic pathology associated with gall bladder cholecystitis. The gene discussed is CRP; the disease is Colonic diverticula.